Manning & Napier Advisors’s Core Laboratories CLB Stock Holding History

Manning & Napier Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-29,570	Closed	-$3.09M	–	358
2015 Q1	$3.09M	Buy	29,570 +7,570	+34%	+$806K	0.01%	274
2014 Q4	$2.65M	Buy	22,000 +10,710	+95%	+$1.41M	0.01%	286
2014 Q3	$1.65M	Buy	11,290 +7,600	+206%	+$1.17M	0.01%	309
2014 Q2	$616K	Buy	+3,690	New	+$656K	﹤0.01%	351
2014 Q1	–	Sell	-12,610	Closed	-$2.41M	–	374
2013 Q4	$2.41M	Sell	12,610 -60	-0.5%	-$11.2K	0.01%	259
2013 Q3	$2.14M	Sell	12,670 -130	-1%	-$20.2K	0.01%	267
2013 Q2	$1.94M	Buy	+12,800	New	+$1.81M	0.01%	267

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Manning & Napier Advisors's CLB Position: Q2 2015 in Review

Manning & Napier Advisors sold out of Core Laboratories (CLB) in Q2 2015, closing a stake of 29,570 shares — an estimated $3.09M sold.

Manning & Napier Advisors first reported a position in CLB in Q2 2013 and held it in 7 quarters. The position peaked at $3.09M in Q1 2015. 356 funds tracked by Wall St. Rank hold CLB as of Q2 2015.

Manning & Napier Advisors reported no remaining Core Laboratories position as of Q2 2015 after selling out during the quarter.
Manning & Napier Advisors sold 29,570 Core Laboratories shares in Q2 2015, an estimated $3.09M.
Manning & Napier Advisors first reported a position in Core Laboratories in Q2 2013 and held it in 7 quarters.
Manning & Napier Advisors's Core Laboratories position peaked at $3.09M in Q1 2015.
356 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2015.

Based on Manning & Napier Advisors's 13F filing for Q2 2015, filed 8 Jul 2015.